Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed Jun 28, 2024
- Accession no.
- 0001493152-24-025666
- Filed
- Jun 28, 2024
- Trade date
- Jun 27-28, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $142.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −34,103 | $2.26 | −$77,072.78 | 2,232,256 | Indirect | |
| Jun 27, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −12,471 | $2.26 | −$28,184.46 | 90,000 | Indirect | |
| Jun 28, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −12,994 | $2.07 | −$26,897.58 | 2,219,262 | Indirect | |
| Jun 28, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −5,000 | $2.07 | −$10,350 | 85,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.